Change Language

Select Language

Press Release:

Global Autoimmune Disease Diagnosis Market to Grow at 6.4% During 2022-2027, Spurred by Advent of Advanced Technologies

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Autoimmune Disease Diagnosis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global autoimmune disease diagnosis market size reached US$ 3.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.1 Billion by 2027, exhibiting a growth rate (CAGR) of 6.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

An autoimmune disease refers to a condition wherein the immune system attacks and destroys healthy cells, tissues, and organs of the body. In the longer run, it can also lead to abnormal growth of an organ and changes in organ function. Currently, more than 80 different autoimmune disorders have been identified by scientists, out of which Systemic Lupus Erythematosus (SLE), multiple sclerosis, rheumatoid arthritis, and type I diabetes, are the most common. Depending on the disorder, the doctor uses a combination of methods, which include a physical examination, medical history, blood tests, biopsy, and X-rays, to provide an effective diagnosis. They prescribe anti-inflammatory and immunosuppressant drugs, physical therapy, surgery, and injections, to control the overactive immune response and provide relief from symptoms.

Owing to the rising prevalence of autoimmune diseases, healthcare professionals around the world are focusing on the adoption of advanced technologies to conduct multiple tests with faster and more precise results. Apart from this, a large number of research and diagnostics institutes are undertaking public awareness campaigns to educate individuals about autoimmune diseases and their possible treatments and diagnosis, which is positively influencing the market growth. Furthermore, several governing authorities, along with non-governing organizations, are funding various programs to develop novel therapeutics. For instance, the AMP RA/SLE Program, launched by the Accelerating Medicines Partnership (AMP), is a public-private partnership between the National Institutes of Health (NIH), the US Food and Drug Administration (FDA) and multiple non-profit organizations. The program aims to identify relevant drug targets for the treatment of autoimmune diseases.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global autoimmune disease diagnosis market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, disease type, test type and end-user.

Breakup by Product Type:

  • Consumables and Assay Kits
  • Instruments
     

Breakup by Disease Type:

  • Systemic Autoimmune Disease
    • Rheumatoid Arthritis
    • Psoriasis
    • Systemic Lupus Erythematosus (SLE)
    • Multiple Sclerosis
    • Others
  • Localized Autoimmune Disease
    • Inflammatory Bowel Disease
    • Type 1 Diabetes
    • Thyroid
    • Others
       

Breakup by Test Type:

  • Routine Laboratory Tests
  • Inflammatory Markers
  • Autoantibodies and Immunologic Tests
  • Others
     

Breakup by End-User:

  • Clinical Laboratories
  • Hospitals
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

 

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, AESKU.GROUP, Danaher Corp., bioMérieux SA, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hemagen Diagnostics, Inc., Inova Diagnostics, Inc., Myriad Genetics, Inc., Quest Diagnostics Incorporated, Siemens Healthineers AG, SQI Diagnostics, Thermo Fisher Scientific Inc., and Trinity Biotech plc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product Type, Disease Type, Test Type, End-User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered  Abbott Laboratories, AESKU.GROUP, Danaher Corp., bioMérieux SA, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hemagen Diagnostics, Inc., Inova Diagnostics, Inc., Myriad Genetics, Inc., Quest Diagnostics Incorporated, Siemens Healthineers AG, SQI Diagnostics, Thermo Fisher Scientific Inc., and Trinity Biotech plc
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology 
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Autoimmune Disease Diagnosis Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product Type
    6.1    Consumables and Assay Kits
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Instruments
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Disease Type
    7.1    Systemic Autoimmune Disease
        7.1.1 Market Trends
        7.1.2 Market Breakup by Type
           7.1.2.1 Rheumatoid Arthritis
           7.1.2.2 Psoriasis
           7.1.2.3 Systemic Lupus Erythematosus (SLE)
           7.1.2.4 Multiple Sclerosis
           7.1.2.5 Others
        7.1.3 Market Forecast
    7.2    Localized Autoimmune Disease
        7.2.1 Market Trends
        7.2.2 Market Breakup by Type
           7.2.2.1 Inflammatory Bowel Disease
           7.2.2.2 Type 1 Diabetes
           7.2.2.3 Thyroid
           7.2.2.4 Others
        7.2.3 Market Forecast
8   Market Breakup by Test Type
    8.1    Routine Laboratory Tests
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Inflammatory Markers
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Autoantibodies and Immunologic Tests
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by End-User
    9.1    Clinical Laboratories
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Hospitals
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abbott Laboratories
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio 
           14.3.1.3 Financials 
           14.3.1.4 SWOT Analysis
        14.3.2    AESKU.GROUP
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Danaher Corp.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio 
           14.3.3.3 SWOT Analysis
        14.3.4   bioMérieux SA
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio 
           14.3.4.3 Financials 
           14.3.4.4 SWOT Analysis
        14.3.5    Bio-Rad Laboratories Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio 
           14.3.5.3 Financials 
           14.3.5.4 SWOT Analysis
        14.3.6    PerkinElmer Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio 
           14.3.6.3 Financials
        14.3.7    Hemagen Diagnostics, Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Inova Diagnostics, Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio 
        14.3.9    Myriad Genetics, Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials 
           14.3.9.4 SWOT Analysis
        14.3.10    Quest Diagnostics Incorporated
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio 
           14.3.10.3 Financials 
           14.3.10.4 SWOT Analysis
        14.3.11    Siemens Healthineers AG
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio 
           14.3.11.3 Financials
        14.3.12    SQI Diagnostics
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio 
           14.3.12.3 Financials
        14.3.13    Thermo Fisher Scientific Inc.
           14.3.13.1 Company Overview
           14.3.13.2 Product Portfolio 
           14.3.13.3 Financials 
           14.3.13.4 SWOT Analysis
        14.3.14    Trinity Biotech plc
           14.3.14.1 Company Overview
           14.3.14.2 Product Portfolio 
           14.3.14.3 Financials 
           14.3.14.4 SWOT Analysis

 
List of Figures

Figure 1: Global: Autoimmune Disease Diagnosis Market: Major Drivers and Challenges
Figure 2: Global: Autoimmune Disease Diagnosis Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Autoimmune Disease Diagnosis Market: Breakup by Product Type (in %), 2021
Figure 4: Global: Autoimmune Disease Diagnosis Market: Breakup by Disease Type (in %), 2021
Figure 5: Global: Autoimmune Disease Diagnosis Market: Breakup by Test Type (in %), 2021
Figure 6: Global: Autoimmune Disease Diagnosis Market: Breakup by End-User (in %), 2021
Figure 7: Global: Autoimmune Disease Diagnosis Market: Breakup by Region (in %), 2021
Figure 8: Global: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 9: Global: Autoimmune Disease Diagnosis (Consumables and Assay Kits) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Autoimmune Disease Diagnosis (Consumables and Assay Kits) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Autoimmune Disease Diagnosis (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Autoimmune Disease Diagnosis (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Autoimmune Disease Diagnosis (Systemic Autoimmune Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Autoimmune Disease Diagnosis (Systemic Autoimmune Disease) Market: Breakup by Disease Type (in %), 2021
Figure 15: Global: Autoimmune Disease Diagnosis (Systemic Autoimmune Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Autoimmune Disease Diagnosis (Localized Autoimmune Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Autoimmune Disease Diagnosis (Localized Autoimmune Disease) Market: Breakup by Disease Type (in %), 2021
Figure 18: Global: Autoimmune Disease Diagnosis (Localized Autoimmune Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Autoimmune Disease Diagnosis (Routine Laboratory Tests) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Autoimmune Disease Diagnosis (Routine Laboratory Tests) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Autoimmune Disease Diagnosis (Inflammatory Markers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Autoimmune Disease Diagnosis (Inflammatory Markers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Autoimmune Disease Diagnosis (Autoantibodies and Immunologic Tests) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Autoimmune Disease Diagnosis (Autoantibodies and Immunologic Tests) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Autoimmune Disease Diagnosis (Other Test Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Autoimmune Disease Diagnosis (Other Test Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Autoimmune Disease Diagnosis (Clinical Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Autoimmune Disease Diagnosis (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Autoimmune Disease Diagnosis (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Autoimmune Disease Diagnosis (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Autoimmune Disease Diagnosis (Other End-Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Autoimmune Disease Diagnosis (Other End-Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: North America: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: North America: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: United States: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: United States: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Canada: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Canada: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Asia Pacific: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Asia Pacific: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: China: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: China: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Japan: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Japan: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: India: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: India: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: South Korea: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: South Korea: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Australia: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Australia: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Indonesia: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Indonesia: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Others: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Others: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Europe: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Europe: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Germany: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Germany: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: France: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: France: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: United Kingdom: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: United Kingdom: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Italy: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Italy: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Spain: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Spain: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Russia: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Russia: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Others: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Others: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Latin America: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Latin America: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Brazil: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Brazil: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Mexico: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Mexico: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Others: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Others: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Middle East and Africa: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Middle East and Africa: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Global: Autoimmune Disease Diagnosis Industry: SWOT Analysis
Figure 82: Global: Autoimmune Disease Diagnosis Industry: Value Chain Analysis
Figure 83: Global: Autoimmune Disease Diagnosis Industry: Porter’s Five Forces Analysis


List of Tables

Table 1: Global: Autoimmune Disease Diagnosis Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 3: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Disease Type (in Million US$), 2022-2027
Table 4: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Test Type (in Million US$), 2022-2027
Table 5: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by End-User (in Million US$), 2022-2027
Table 6: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Autoimmune Disease Diagnosis Market Structure
Table 8: Global: Autoimmune Disease Diagnosis Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global autoimmune disease diagnosis market was valued at US$ 3.5 Billion in 2021.

Sudden outbreak of the COVID-19 pandemic had led to the postponement of numerous elective diagnosis procedures, including blood tests, biopsy, X-rays, physical therapy, etc., for reducing the risk of coronavirus infection upon interaction with healthcare professionals or equipment.

We expect the global autoimmune disease diagnosis market to exhibit a CAGR of 6.4% during 2022-2027.

The rising adoption of numerous advanced technologies to conduct multiple tests simultaneously with faster and accurate results is currently driving the global autoimmune disease diagnosis market.

Based on the product type, the market has been bifurcated into consumables and assay kits, and instruments. Currently, consumables and assay kits hold the majority of the total market share.

Based on the disease type, the market can be divided into systemic autoimmune disease and localized autoimmune disease. Amongst these, localized autoimmune disease currently accounts for the majority of the total market share.

Based on the test type, the market has been segmented into routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and others. Currently, routine laboratory tests exhibit a clear dominance in the market.

On a regional level, the market has been segmented into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global autoimmune disease diagnosis market include Abbott Laboratories, AESKU.GROUP, Danaher Corp., bioMérieux SA, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hemagen Diagnostics, Inc., Inova Diagnostics, Inc., Myriad Genetics, Inc., Quest Diagnostics Incorporated, Siemens Healthineers AG, SQI Diagnostics, Thermo Fisher Scientific Inc., and Trinity Biotech plc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Androgenetic Alopecia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033

Read More

Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Region 2023-2028

Read More

Behcet's Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033

Read More

Catheter-Related Bloodstream Infections (CRBSIs) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033

Read More

RFID Blood Refrigerators and Freezers Market by Types (RFID Refrigerators, RFID Freezers), Applications (Hospitals and Diagnostic Centers, Blood Banks, and Others), and Region 2023-2028

Read More

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )

Drop us an email at

sales@imarcgroup.com

Social Links

4